Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.12 USD | -8.35% | +19.08% | +12.10% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 44.94M | Capitalization | 1.51B |
---|---|---|---|---|---|
Net income 2024 * | -57M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | 139M | Net cash position 2025 * | 99.6M | EV / Sales 2025 * | 31.3 x |
P/E ratio 2024 * |
-28.9
x | P/E ratio 2025 * |
-59.9
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.79% |
Latest transcript on Soleno Therapeutics, Inc.
1 day | -8.35% | ||
1 week | +19.08% | ||
Current month | +1.03% | ||
1 month | +8.05% | ||
3 months | -3.47% | ||
6 months | +94.65% | ||
Current year | +12.10% |
Managers | Title | Age | Since |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 19-11-13 |
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 19-04-25 |
Bill Harris
BRD | Director/Board Member | 65 | 14-06-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 45.12 | -8.35% | 1,599,401 |
24-05-02 | 49.23 | +3.55% | 322,146 |
24-05-01 | 47.54 | +6.45% | 433,159 |
24-04-30 | 44.66 | -1.91% | 809,441 |
24-04-29 | 45.53 | +20.16% | 3,503,649 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.10% | 1.51B | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- SLNO Stock